Affordable Access

deepdyve-link
Publisher Website

An evidence-based review of a Lentinula edodes mushroom extract as complementary therapy in the surgical oncology patient.

Authors
  • Shah, Shinil K
  • Walker, Peter A
  • Moore-Olufemi, Stacey D
  • Sundaresan, Alamelu
  • Kulkarni, Anil D
  • Andrassy, Richard J
Type
Published Article
Journal
JPEN. Journal of parenteral and enteral nutrition
Publication Date
Jul 01, 2011
Volume
35
Issue
4
Pages
449–458
Identifiers
DOI: 10.1177/0148607110380684
PMID: 21628606
Source
Medline
License
Unknown

Abstract

The purpose of this review is to present the currently published evidence regarding the use, efficacy, potential mechanisms of action, and results of published clinical trials regarding the use of a Lentinula edodes mushroom-derived extract (active hexose correlated compound) as complementary therapy in patients with cancer. The authors explore the current preclinical and clinical evidence as it relates to this topic and its potential use in the surgical oncology patient. There has been a growing interest in stimulation of the immune system in trauma, cancer, and surgical patients in general. Little, however, has been written about some-of the supplements in widely used in Japan and China, but relatively unheard of in the United States.

Report this publication

Statistics

Seen <100 times